Originator Organization Iambic Therapeutics, Inc.Startup |
Active Organization Iambic Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | Iambic Therapeutics, Inc.Startup | 06 Jul 2024 |